83 related articles for article (PubMed ID: 8105374)
21. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
[TBL] [Abstract][Full Text] [Related]
22. Time course of MDR gene amplification during in vivo selection for doxorubicin-resistance and during reversal in murine leukemia L 1210.
Volm M; Mattern J; Pommerenke EW
Anticancer Res; 1991; 11(2):579-85. PubMed ID: 1676579
[TBL] [Abstract][Full Text] [Related]
23. Changes in phosphate metabolism in thymoma cells suggest mechanisms for resistance to dexamethasone-induced apoptosis. A 31P NMR spectroscopic study of cell extracts.
Lutz NW; Tome ME; Aiken NR; Briehl MM
NMR Biomed; 2002 Aug; 15(5):356-66. PubMed ID: 12203227
[TBL] [Abstract][Full Text] [Related]
24. Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth.
Tome ME; Baker AF; Powis G; Payne CM; Briehl MM
Cancer Res; 2001 Mar; 61(6):2766-73. PubMed ID: 11289160
[TBL] [Abstract][Full Text] [Related]
25. Expression of the mdr1 P-glycoprotein gene: a mechanism of escape from glucocorticoid-induced apoptosis.
Gruol DJ; Bourgeois S
Biochem Cell Biol; 1994; 72(11-12):561-71. PubMed ID: 7654329
[TBL] [Abstract][Full Text] [Related]
26. Profound differences in the transport of steroids by two mouse P-glycoproteins.
Gruol DJ; Vo QD; Zee MC
Biochem Pharmacol; 1999 Oct; 58(7):1191-9. PubMed ID: 10484077
[TBL] [Abstract][Full Text] [Related]
27. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
28. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
29. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
Kantharidis P; El-Osta A; deSilva M; Wall DM; Hu XF; Slater A; Nadalin G; Parkin JD; Zalcberg JR
Clin Cancer Res; 1997 Nov; 3(11):2025-32. PubMed ID: 9815593
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the multidrug resistance gene in regenerating rat liver.
Marino PA; Gottesman MM; Pastan I
Cell Growth Differ; 1990 Feb; 1(2):57-62. PubMed ID: 1982215
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH
Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677
[TBL] [Abstract][Full Text] [Related]
32. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates.
Schrenk D; Gant TW; Preisegger KH; Silverman JA; Marino PA; Thorgeirsson SS
Hepatology; 1993 May; 17(5):854-60. PubMed ID: 8098315
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells.
Chapman MS; Askew DJ; Kuscuoglu U; Miesfeld RL
Mol Endocrinol; 1996 Aug; 10(8):967-78. PubMed ID: 8843413
[TBL] [Abstract][Full Text] [Related]
34. The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein.
Buschman E; Gros P
Cancer Res; 1994 Sep; 54(18):4892-8. PubMed ID: 7915194
[TBL] [Abstract][Full Text] [Related]
35. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.
Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH
Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431
[TBL] [Abstract][Full Text] [Related]
36. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
37. Effect of differentiating agents on modulation of MDR1 gene expression in multidrug-resistant hematopoietic HL60/DNR cell line.
Zhou DC; Marie JP; Maisonneuve L; Faussat-Suberville AM; Zittoun R
Exp Hematol; 1993 Jun; 21(6):779-84. PubMed ID: 8099018
[TBL] [Abstract][Full Text] [Related]
38. Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes.
Fardel O; Lecureur V; Guillouzo A
FEBS Lett; 1993 Jul; 327(2):189-93. PubMed ID: 8101494
[TBL] [Abstract][Full Text] [Related]
39. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
Wang G; Rong J; Zhou Z; Duo J
Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
[TBL] [Abstract][Full Text] [Related]
40. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN
Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
